Enhanced expression of vascular endothelial growth factor in metastatic melanoma
about
The role of miRNAs in cutaneous squamous cell carcinomaVEGFR-2 expression in human melanoma: revised assessment.Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis.Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanoma.Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775Lymphangiogenesis and its correlation with the VEGF expression and the sentinel lymph node in cutaneous melanomas.Angiogenesis and progression in human melanoma.The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinomaRecent advances in cutaneous angiogenesis.Dermatological aspects of angiogenesis.Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling.Angiogenesis, lymphangiogenesis, and melanoma metastasis.Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanomaThe combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial.Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma.Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors.Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.The Roles of Angiogenesis in Malignant Melanoma: Trends in Basic Science Research over the Last 100 Years.The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops.Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model.BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma.A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines.Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.ECOG phase II trial of graded-dose peginterferon α-2b in patients with metastatic melanoma overexpressing basic fibroblast growth factor (E2602)Current systemic therapy for metastatic melanoma.Emergence of potential biomarkers of response to anti-angiogenic anti-tumour agents.Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?Why is melanoma so metastatic?Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma - implications for therapeutic strategies and targeted therapies.Predicting lymph node metastasis in patients with papillary thyroid carcinoma by vascular index on power Doppler ultrasound.Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.DNA aptamer raised against advanced glycation end products inhibits melanoma growth in nude mice.In vitro antimetastatic effect of Changweiqing through antiinvasion of hypoxic colorectal carcinoma LoVo cells.The role of VEGF in melanoma progression.Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma.Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate.Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients.
P2860
Q26778339-B84F6361-8110-4D79-887C-0D1B2DACF232Q30423356-C4AA9F12-0D13-42AE-8FD4-C7E71367B206Q30438929-CD07229B-AC00-4590-9EF7-D490DB554526Q31774297-EDF7968D-CE11-45DC-97BA-9EB5F4C96B92Q33379895-E5A6187B-E3ED-4093-AE40-47B3737C4691Q33382481-6D6688B7-5492-4651-97D2-9EF703C86D4CQ33871014-4FBEF170-E3B9-44E1-BED0-1195EA62DFCCQ33894060-5D9A7D74-25DC-4DF4-AB15-393ACECC1098Q33982978-EBF2AC43-8678-4577-BD78-4E6CD2651B6CQ34482531-4900CA9C-0405-46FA-85ED-4515EDE65AD5Q34808162-83A4B0D8-3A93-41B3-8185-B6FEF1B43BFFQ34985953-52D93A1A-2851-461C-9598-38C4F85D6417Q35103539-D8901C54-EF95-4A4D-AA02-749E47452D95Q35146591-FB912D87-C3E5-49DD-AF8A-6C48B4A02491Q35234354-2CF1C1BF-95D3-441A-93B0-F3F0015CD34EQ35475284-4777B105-57BD-4FD9-8805-A899AFCFFFBFQ35746653-45D3705C-0F75-439A-9385-381AC659FA66Q35747496-C66CB9A9-3D73-4BAF-B69C-AAF0699F98AEQ35753219-D6E06C86-22C5-477A-B406-1B8A14D0D1CEQ35791518-D51B6321-6F56-4532-AEF7-6DC07FE7682FQ36037600-F718F8F6-8CD0-49FA-968E-24C7E49D8B69Q36172732-E0DEEE20-EEE6-4983-97C4-FDE2BFE050A0Q36218573-EF4DD8CF-82A9-4621-858C-24A1FDC58C7DQ36346020-A9373C3B-CAAB-4501-8BE8-C1B600E273F4Q36620703-C7E4E500-FEDB-4BC9-A8ED-530183BD595AQ37288883-3FD41570-A680-46DA-A4D7-936232E10451Q37383950-5EDD0E1A-DAE5-4711-AB32-B395361423B0Q37483961-A5CCAE35-4ED2-4C4A-BE67-396598CC1D71Q37754126-7BCF4C73-DA23-4F55-83FA-F65E22B180DFQ37846342-5784EE36-5B96-4F36-966B-D7CA359EF26FQ38150869-F3D59752-EF9A-4F2C-BB8F-FE79EFFCA6F6Q38186064-1AF533D6-5ACC-4FA5-BD88-55713AAD4D31Q38410144-E025F7FB-CC8B-4654-B76D-BCC2C8F66888Q38429857-456D5669-52F3-44EC-890B-A6BEA9336A1DQ39025239-3BD2ADC6-64CB-4B1E-A08B-4BC9A7839711Q39513386-ED3FD93C-6728-4661-BF3F-9F54FC499B2FQ40038149-A161ABE1-CB68-41C7-AC50-875E1B559431Q40532078-5DB5033C-D077-4E9A-B0F2-C55BC33BF479Q40617744-A41215F4-1B22-4C53-B51C-F864600C7A61Q42488475-DA802110-CA8B-4DFC-92F9-916666B50AA6
P2860
Enhanced expression of vascular endothelial growth factor in metastatic melanoma
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Enhanced expression of vascular endothelial growth factor in metastatic melanoma
@ast
Enhanced expression of vascular endothelial growth factor in metastatic melanoma
@en
type
label
Enhanced expression of vascular endothelial growth factor in metastatic melanoma
@ast
Enhanced expression of vascular endothelial growth factor in metastatic melanoma
@en
prefLabel
Enhanced expression of vascular endothelial growth factor in metastatic melanoma
@ast
Enhanced expression of vascular endothelial growth factor in metastatic melanoma
@en
P2093
P2860
P356
P1476
Enhanced expression of vascular endothelial growth factor in metastatic melanoma
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1997.486
P407
P577
1997-01-01T00:00:00Z